{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:47:43Z","timestamp":1768880863876,"version":"3.49.0"},"reference-count":41,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2025,1,25]]},"DOI":"10.23922\/jarc.2024-077","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T22:13:01Z","timestamp":1737756781000},"page":"117-126","source":"Crossref","is-referenced-by-count":6,"title":["Radiomics-based Machine Learning Approach to Predict Chemotherapy Responses in Colorectal Liver Metastases"],"prefix":"10.23922","volume":"9","author":[{"given":"Yuji","family":"Miyamoto","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakaura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Ohuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Eto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Iwatsuki","sequence":"additional","affiliation":[{"name":"Division of Translational Research and Advanced Treatment Against Gastrointestinal Cancer, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Next-Generation Surgical Therapy Development, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71 (3): 209-49.","DOI":"10.3322\/caac.21660"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Galizia G, Lieto E, Orditura M, et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg [Internet]. 2008; 143 (4): 352-8. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18427022","DOI":"10.1001\/archsurg.143.4.352"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Engstrand J, Nilsson H, Str\u00f6mberg C, et al. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018 Jan; 18 (1): 78.","DOI":"10.1186\/s12885-017-3925-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Adam RRR, Wicherts DA, de Haas RJ, et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol. 2008 Apr; 26 (10): 1635-41.","DOI":"10.1200\/JCO.2007.13.7471"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Overman MJ, Lonardi S, Yeung K, et al. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient\/Microsatellite Instability-High Metastatic Colorectal Cancer. J Clin Oncol. 2018; 36 (8): 773-9.","DOI":"10.1200\/JCO.2017.76.9901"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miyamoto Y, Lenz H-J, Baba H. A novel antimetabolite: TAS-102 for metastatic colorectal cancer. Expert Rev Clin Pharmacol [Internet]. 2016; 9 (3): 355-65. Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/17512433.2016.1133285","DOI":"10.1586\/17512433.2016.1133285"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Loupakis F, Cremolini C, Masi G, et al. Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer. N Engl J Med. 2014; 371 (17): 1609-18.","DOI":"10.1056\/NEJMoa1403108"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Holch JW, Ricard I, Stintzing S, et al. The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. Eur J Cancer [Internet]. 2017; 70: 87-98. Available from: http:\/\/dx.doi.org\/10.1016\/j.ejca.2016.10.007","DOI":"10.1016\/j.ejca.2016.10.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Douillard J-Y, Oliner KS, Siena S, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med [Internet]. 2013 Sep; 369 (11): 1023-34. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24024839","DOI":"10.1056\/NEJMoa1305275"},{"key":"10","unstructured":"10. Sartore-Bianchi A, Trusolino L, Martino C, et al. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12\/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Lancet Oncol [Internet]. 2016; 17 (6): 738-46. Available from: http:\/\/dx.doi.org\/10.1016\/S1470-2045 (16) 00150-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018 Dec; 15 (12): 731-47.","DOI":"10.1038\/s41571-018-0113-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer imaging. 2013 Mar; 13 (1): 140-9.","DOI":"10.1102\/1470-7330.2013.0015"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ahn SJ, Kim JH, Park SJ, et al. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol [Internet]. 2016; 85 (10): 1867-74. Available from: http:\/\/dx.doi.org\/10.1016\/j.ejrad.2016.08.014","DOI":"10.1016\/j.ejrad.2016.08.014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lee SJ, Zea R, Kim DH, et al. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer. Eur Radiol. 2018 Apr; 28 (4): 1520-8.","DOI":"10.1007\/s00330-017-5111-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ravanelli M, Agazzi GM, Tononcelli E, et al. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy. Radiol Med [Internet]. 2019; 124 (9): 877-86. Available from: http:\/\/link.springer.com\/10.1007\/s11547-019-01046-4","DOI":"10.1007\/s11547-019-01046-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Masuda T, Nakaura T, Funama Y, et al. Machine learning to identify lymph node metastasis from thyroid cancer in patients undergoing contrast-enhanced CT studies. Radiogr. 2021 Aug; 27 (3): 920-6.","DOI":"10.1016\/j.radi.2021.03.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang Y, Li X, Lv Y, et al. Review of Value of CT Texture Analysis and Machine Learning in Differentiating Fat-Poor Renal Angiomyolipoma from Renal Cell Carcinoma. Tomogr (Ann Arbor, Mich). 2020 Dec; 6 (4): 325-32.","DOI":"10.18383\/j.tom.2020.00039"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lubner MG. Radiomics and Artificial Intelligence for Renal Mass Characterization. Radiol Clin North Am. 2020 Sep; 58 (5): 995-1008.","DOI":"10.1016\/j.rcl.2020.06.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chang R, Qi S, Yue Y, et al. Predictive Radiomic Models for the Chemotherapy Response in Non-Small-Cell Lung Cancer based on Computerized-Tomography Images. Front Oncol. 2021; 11: 646190.","DOI":"10.3389\/fonc.2021.646190"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Qi TH, Hian OH, Kumaran AM, et al. Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer. Breast Cancer Res Treat. 2022 May; 193 (1): 121-38.","DOI":"10.1007\/s10549-022-06521-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zhu Y, Yao W, Xu B-C, et al. Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers. BMC Cancer. 2021 Oct; 21 (1): 1167.","DOI":"10.1186\/s12885-021-08899-x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Oncol. 2005 Aug; 2 (8): 416-22.","DOI":"10.1038\/ncponc0252"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 2017 Nov; 77 (21): e104-7.","DOI":"10.1158\/0008-5472.CAN-17-0339"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Degenhardt F, Seifert S, Szymczak S. Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform. 2019 Mar; 20 (2): 492-503.","DOI":"10.1093\/bib\/bbx124"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kursa MB, Jankowski A, Rudnicki WR. Boruta - A system for feature selection. Fundam Informaticae. 2010; 101 (4): 271-85.","DOI":"10.3233\/FI-2010-288"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Breiman L. Random Forests. Mach Learn [Internet]. 2001; 45 (1): 5-32. Available from: https:\/\/doi.org\/10.1023\/A:1010933404324","DOI":"10.1023\/A:1010933404324"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Dercle L, Lu L, Schwartz LH, et al. Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway. J Natl Cancer Inst. 2020 Sep; 112 (9): 902-12.","DOI":"10.1093\/jnci\/djaa017"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Giannini V, Pusceddu L, Defeudis A, et al. Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases. Cancers (Basel). 2022 Jan; 14 (1).","DOI":"10.3390\/cancers14010241"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Dohan A, Gallix B, Guiu B, et al. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab. Gut. 2020 Mar; 69 (3): 531-9.","DOI":"10.1136\/gutjnl-2018-316407"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Qi W, Yang J, Zheng L, et al. CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy. Med Phys. 2023 May; 50 (5): 2705-14.","DOI":"10.1002\/mp.16325"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wei J, Cheng J, Gu D, et al. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases. Med Phys. 2021 Jan; 48 (1): 513-22.","DOI":"10.1002\/mp.14563"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Garc\u00eda-Alb\u00e9niz X, Alonso V, Escudero P, et al. Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02). Oncologist. 2019 Nov; 24 (11): e1115-22.","DOI":"10.1634\/theoncologist.2018-0728"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang X, Ghareeb WM, Zhang Y, et al. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer. J Cell Physiol. 2019 Aug; 234 (10): 18180-91.","DOI":"10.1002\/jcp.28451"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Chen Q, Xia H-W, Ge X-J, et al. Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases. Asian Pac J Cancer Prev. 2013; 14 (12): 7421-6.","DOI":"10.7314\/APJCP.2013.14.12.7421"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Neerincx M, Poel D, Sie DLS, et al. Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer. PLoS One. 2018; 13 (8): e0201809.","DOI":"10.1371\/journal.pone.0201809"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Herbst A, Vdovin N, Gacesa S, et al. Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer. Int J cancer. 2017 May; 140 (9): 2134-44.","DOI":"10.1002\/ijc.30625"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Incoronato M, Aiello M, Infante T, et al. Radiogenomic analysis of oncological data: A technical survey. Int J Mol Sci. 2017; 18 (4): 1-28.","DOI":"10.3390\/ijms18040805"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Rizzo S, Botta F, Raimondi S, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. 2018; 2 (1): 36.","DOI":"10.1186\/s41747-018-0068-z"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012 Mar; 48 (4): 441-6.","DOI":"10.1016\/j.ejca.2011.11.036"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Mazurowski MA. Radiogenomics: what it is and why it is important. J Am Coll Radiol. 2015 Aug; 12 (8): 862-6.","DOI":"10.1016\/j.jacr.2015.04.019"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Bai HX, Lee AM, Yang L, et al. Imaging genomics in cancer research: limitations and promises. Br J Radiol. 2016; 89 (1061): 20151030.","DOI":"10.1259\/bjr.20151030"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-077\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:54:55Z","timestamp":1737780895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-077\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2024-077","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"article-number":"2024-077"}}